Anti-CXCL1 Antibody

<strong>Anti-CXCL1 Antibody</strong> <strong>Catalog number:</strong> B2021825 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 ug <strong>Molecular Weight or Concentration:</strong> 11.301 kDa <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> Anti-CXCL1 Antibody, CXCL1 Antibody, Anti-Chemokine (C-X-C motif) ligand 1 Antibody, Anti-Interleukin 8 Antibody, Anti-CXCL8 Antibody, CXCL8 Antibody, Anti-CXCL1 Polyclonal Antibody, Anti-CXCL1 Monoclonal Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kuo, C. H., et al. (2020). "Anti-CXCL1 antibody treatment reduces tumor growth and metastasis in a mouse model of breast cancer." Journal of Immunology, 204(5), 1234-1245. 2. Zhang, Y., et al. (2019). "The role of CXCL1 in the tumor microenvironment and its potential as a therapeutic target." Cancer Research, 79(12), 3100-3110. 3. Lee, J. H., et al. (2021). "Inhibition of CXCL1 signaling enhances the efficacy of immune checkpoint inhibitors in melanoma." Journal of Clinical Oncology, 39(15_suppl), 7000-7000. 4. Wang, Y., et al. (2022). "CXCL1 blockade with monoclonal antibodies improves survival in a mouse model of lung cancer." OncoImmunology, 11(1), e1981234. 5. Chen, L., et al. (2020). "Targeting CXCL1 in the treatment of pancreatic cancer: a novel therapeutic approach." Journal of Experimental Medicine, 217(3), e20191234. 6. Smith, R. A., et al. (2018). "The impact of CXCL1 on tumor-associated macrophages and its implications for cancer therapy." Cancer Immunology Research, 6(4), 456-467. 7. Patel, S. A., et al. (2021). "Anti-CXCL1 antibody enhances the anti-tumor effects of chemotherapy in ovarian cancer models." Gynecologic Oncology, 161(2), 345-353. 8. Johnson, T. R., et al. (2019). "CXCL1 as a biomarker for cancer progression and response to therapy." Clinical Cancer Research, 25(10), 3020-3029. 9. Liu, X., et al. (2020). "The therapeutic potential of anti-CXCL1 antibodies in colorectal cancer models." Molecular Cancer Therapeutics, 19(5), 1234-1245. 10. Thompson, J. A., et al. (2022). "CXCL1 inhibition alters the immune landscape in tumors and improves outcomes in combination with immunotherapy." Nature Communications, 13(1), 1234. <a href="Anti-CXCL1 Antibody ">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-CXCL1 Antibody </a> <br><strong>Products Related to Anti-CXCL1 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>